News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Novalar Pharmaceuticals, Inc. Plans Shutdown Following Sale of OraVerse to Septodont, to Cut 12 Jobs
March 23, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy -- It turns out that Novalar Pharmaceuticals’ decision to sell OraVerse, its dental anesthesia reversal agent, was only half the story.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
MORE ON THIS TOPIC
Layoff Tracker
Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds
March 12, 2026
·
34 min read
·
BioSpace Editorial Staff
Job Trends
The Next Cambridge? LA Sets Its Sights Higher
March 12, 2026
·
5 min read
·
Angela Gabriel
Job Trends
Hiring Outlook: February Brings First YOY Job Increase Since 2022
March 12, 2026
·
4 min read
·
Angela Gabriel
Job Trends
6 Companies Hiring in Cambridge
March 11, 2026
·
1 min read
·
Angela Gabriel
